Abstract
Thyroid stimulating hormone (TSH), or thyrotropin, is a glycoprotein normally secreted by the thyrotroph cells of the anterior pituitary gland. Like the other pituitary glycoproteins, TSH is composed of an alpha (α) and a beta (β) subunit. The α-subunit is identical among the glycoprotein hormones, whereas the unique TSH β-subunit confers biological specificity to the hormone. The TSH α and β subunits are glycosylated in specific patterns that determine subunit combination, clearance rates, and bioactivity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mindermann T, Wilson CB. Thyrotropin-producing pituitary adenomas. J Neurosurg 1993;79:521–527.
Smallridge RC. Thyrotropin-secreting tumors. In: Mazzaferri EL, Samaan NA, eds. Endocrine Tumors. Blackwell, Boston, 1993, pp. 136–151.
Gesundheit N, Petrick PA, Nissim M. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Ann Int Med 1989; 111:827–835.
Beckers A, Abs R, Mahler C, et al. Thyrotropin-secreting pituitary adenomas: report of seven cases. J Clin Endocrinol Metab 1991; 72:477–483.
Felix I, Asa SL, Kovacs K, et al. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin. Arch Pathol Lab Med 1994; 118:66–70.
Patrick AW, Atkin SL, MacKenzie, et al. Hyperthyroidism secondary to a pituitary adenoma secreting TSH, FSH, alpha-subunit and GH. Clin Endocrinol 1994; 40:275–278.
Magner J. TSH-mediated hyperthyroidism. The Endocrinologist 1993; 3:289–296.
Burgess JR, Shepherd JJ, Greenaway TM. Thyrotropinomas in multiple endocrine neoplasia type 1 (MEN-1). Aust NZ J Med 1994; 24:740–1.
Gessl A, Freissmuth M, Czech T, et al. Growth hormone-prolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gsα protein. J Clin Endocrinol Metab 1994;79:1128–1134.
Mixsen AJ, Friedman TC, Katz DA. Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 1993; 76:529–533.
Refetoff S. Resistance to thyroid hormone revisited. Thyroid Today 1990; 13:1–11.
Beck-Peccoz P, Chatterjee KK. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 1994; 4:225–232.
Usula S J. Molecular diagnosis and characterization of thyroid hormone resistance syndromes. Thyroid 1991; 1:361–367.
Beck-Peccoz P, Roncoroni R, Mariotti S et al. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab 1990; 71:19–25.
Smallridge RC. Thyrotropin-secreting pituitary tumors. Endocrinology and Metabolism Clinics 1987; 16:765–792.
Fatourechi V, Gharib H, Scheithauer BW. et al. Pituitary thyrotropic adenoma associated with congenital hypothyroidism. Am J Med 1984; 76:725–728.
Boggild MD, Jenkinson S, Pistorello M. et al. Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metab 1994; 78:387–392.
Cryns VL, Alexander JM, Klibanski A, Arnold A. The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab 1993; 77:644–646.
Zhu J, Leon SP, Beggs AH. et al. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J Clin Endocrinol Metab 1994; 78:922–927.
Karga HJ, Alexander JM, Hedley-White ET. et al. Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 1992; 74:914–919.
Woloschak M, Roberts JL, Post K. C-myc, c-fos, and c-myb gene expression in human pituitary adenomas. J Clin Endocrinol Metab 1994; 79:253–7.
Pellegrini I, Barlier A, Gunz G. et al. Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 1994; 79:189–96.
Asa SL, Puy LA, Lew AM. et al. Cell type-specific expression of the pituitary transcription activator Pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 1993; 77:1275–80.
Friend KE, Chiou YK, Laws ER. et al. Pit-1 messenger ribonucleic acid is differentially expressed in human pituitary adenomas. J Clin Endocrinol Metab 1993; 77:1281–6.
Samuels MH, Wood WM, Gordon DF. et al. Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma. J Clin Endocrinol Metab 1989; 68:1211–1215.
Wondisford FE, Radovick S, Moates JM. et al. Isolation and characterization of the human thyrotropin β-subunit gene. J Biol Chem 1988; 263:12,538–12,542
Magner J, Klibanski A, Fein H. et al. Ricin and lentil lectin-affinity chromatography reveals oligosaccharide heterogeneity of thyrotropin secreted by 12 human pituitary tumors. Metabolism 1992; 41:1009–1015.
Papandreou M J, Persani L, Asteria C. et al. Variable carbohydrate structures of circulating thyrotropin as studied by lectin affinity chromatography in different clinical conditions. J Clin Endocrinol Metab 1993; 77:393–398.
Samuels MH, Henry P, Kleinschmidt-DeMasters BK. et al. Pulsatile glycoprotein hormone secretion in glycoprotein-producing pituitary tumors. J Clin Endocrinol Metab 1991; 73:1281–1288.
Adriaanse R, Brabant G, Endert E. et al. Pulsatile thyrotropin and prolactin secretion in a patient with a mixed thyrotropin-and prolactin-secreting pituitary adenoma. Eur J Endocrinol 1994; 130:113–20.
Chanson R, Li JY, LeDafniet M, et al. Absence of receptors for thyrotropin (TSH)-releasing hormone in human TSH-secreting pituitary adenomas associated with hyperthyroidism. J Clin Endocrinol Metab 1988; 66:447–450.
Le Dafniet M, Brandi AM, Kujas M, et al. Thyrotropin-releasing hormone (TRH) binding sites and thyrotropin response to TRH are regulated by thyroid hormones in human thyrotropic adenomas. Eur J Endocrinol 1994; 130:559–564.
Chanson P, Orgiazzi J, Derome PJ, et al. Paradoxical response of thyrotropin to 1-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenoma. J Clin Endocrinol Metab 1984; 59:542–546.
Spada A, Bassetti M, Martino E. et al. In vitro studies on TSH secretion and adenylate cyclase activity in a human TSH-secreting pituitary adenoma. Effects of somatostatin and dopamine. J Endocrinol Invest 1985; 8:193–198.
Bertherat J, Brue T, Enjalbert A. et al. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab 1992; 75:540–546.
Takano K, Ajima M, Teramoto A. et al. Mechanisms of action of somatostatin on human TSH-secreting adenoma cells. Am J Physiol 1995; 268:E558–64.
McCutcheon IE, Weintraub BD, Oldfield EH. Surgical treatment of thyrotropin-secreting pituitary adenomas. J Neurosurg 1990; 73:674–683.
Jackson JA, Smigiel M. Hypothyroidism and thyrotropin-secreting pituitary microadenomectomy. Ann Int Med 1990; 112:388.
Karlsson FA, Burman P, Kampe O. et al. Large somatostatin-insensitive thyrotropin-secreting pituitary tumour responsive to d-thyroxine and dopamine agonists. Acta Endocrinol 1993; 129:291–295.
Francis TB, Smallridge RC, Kane J, Magner JA. Octreotide changes serum thyrotropin (TSH) glycoisomer distribution as assessed by lectin chromatography in a TSH macroadenoma patient. J Clin Endocrinol Metab 1993; 77:183–7.
Comi RJ, Gesundheit N, Murray L. et al. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med 1981; 317:12–17.
Chanson P, Weintraub BD, Harris AG. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Int Med 1993; 119:236–240.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Humana Press Inc.
About this chapter
Cite this chapter
Samuels, M.H. (1997). Thyrotropin-Secreting Pituitary Tumors. In: Wierman, M.E. (eds) Diseases of the Pituitary. Contemporary Endocrinology, vol 3. Humana Press. https://doi.org/10.1007/978-1-4612-3954-3_15
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3954-3_15
Publisher Name: Humana Press
Print ISBN: 978-1-4612-8438-3
Online ISBN: 978-1-4612-3954-3
eBook Packages: Springer Book Archive